Oaktree Acquisition Corp. III Life Sciences

NASDAQ:OACC

Shell Companies

Financial Services
$10.72 +0.00%

+$0.00 today

Market cap
$263.53M
Beta
-0.04
P/E (TTM)
29.1
EPS (TTM)
$0.37
52W Low $10.30High $10.74

Volume 0.00M

Average 0.01M

OACC Research & Development

Spending on developing new products, technologies, and improvements to existing offerings.

Oaktree Acquisition Corp. III Life SciencesNASDAQ: OACC

Research & Development · Q1 FY2026 · quarter ended Mar 2026

Research & development remains negative

Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.

What to watch

Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$0— YoY
LTMMar 2026
$0— YoY
Research & Development past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Research & Development history

USD · from the income statement

Latest · FY2025
0 USD
Year-over-year change
—

Research & Development vs competitors

How OACC compares with its peers on the latest reported figures

  • OACC's LTM Mar 2026 research & development of $0 is the highest of the 10 companies compared; the peer median is $0.
OACC Competitors Peer median
Research & Development for OACC and competitors
Company Period LTM YoY 3-year CAGR% of revenue
OACCOaktree Acquisition Corp. III Life SciencesLTM Mar 2026$0 ———
CGCTCartesian Growth Corporation IIILTM Mar 2026$0 ———
MBAVM3-Brigade Acquisition V Corp. Class A Ordinary sharesLTM Mar 2026$0 ———
SOULSoulpower Acquisition Corp.LTM Mar 2026$0 ———
FACTFACT II Acquisition CorpLTM Mar 2026$0 ———
PMTRPerimeter Acquisition Corp. I Class A Ordinary SharesLTM Mar 2026$0 ———
RACRithm Acquisition Corp.LTM Mar 2026$0 ———
AACBArtius II Acquisition Inc. Class A Ordinary SharesLTM Mar 2026$0 ———
COPLCopley Acquisition CorpLTM Mar 2026$0 ———
MLACMountain Lake Acquisition Corp.LTM Mar 2026$0 ———
Peer median (excluding OACC) $0———

Competitors are the stored peer set for OACC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD

Oaktree Acquisition Corp. III Life Sciences

NASDAQ:OACC

Intrinsic Alpha fair value

Locked

Current Price

$10.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.